The FDA has scheduled a ******** and Related Biological Products Advisory Committee (VRBPAC) meeting on Jan. 26 “to discuss the future ******** regimens addressing COVID-19.” The vague description regarding the nature of the upcoming VRBPAC meeting lacks transparency. Regardless of their agenda, we must demand that VRBPAC looks at the data regarding the failure of the COVID-19 "PRODUCTS" program. TAKE ACTION: Submit Comment to VRBPAC 🔗🔗🔗 https://tinyurl.com/323spjes 🔗🔗🔗 in BIO. Approximately 16% of eligible Americans over the age of five have received the bivalent booster. This low uptake, combined with serious safety and efficacy concerns, has not deterred the FDA from moving ahead “at the speed of science” to recommend more shots. VRBPAC is obligated to hear our voices. Submit your public comment to the FDA by Jan.18. Consider using some of these points in your submission: 🔥 Demand answers about the need for future COVID-19 "PRODUCTS" for all age groups when the median infection fatality rate of COVID-19 was estimated to be 0.034% for people aged 0–59 years by Feb. 2021. 🔥 Compel the justification for continuing the booster program for "PRODUCTS" that don’t prevent transmission or infection. 🔥 Share your personal experiences and concerns about the looming mandates that will be imposed once the "PRODUCT" is officially added to the childhood schedule. 🔥 Ask them to stop prioritizing Pharma profits over public health needs and to recognize that "PRODUCT" injury is real, not rare. 🔥 Tell them to explain the data regarding pregnant women and the high miscarriage rate (87.5%) seen among women whose pregnancy outcomes were known. 🔥 Emphasize how egregious it is to authorize a completely experimental product — that didn’t even undergo human trials — for infants as young as six months old. Their job is to protect the people, and it’s our job to hold them accountable. Take immediate action to have your voice heard! Thank you for your help! The Children’s Health Defense Team